M seems in Chest. 2006 Mar;129(3):831]. Chest 2005, 128(six):3854862. 3. Micek ST, Kollef KE, Reichley RM, Roubinian N, Kollef MH: Well being care-associated pneumonia and community-acquired pneumonia: a single-center encounter. Antimicrob Agents Chemother 2007, 51(10):3568573. four. Shorr AF, Zilberberg MD, Micek ST, Kollef MH: Prediction of infection as a consequence of antibiotic-resistant bacteria by pick threat things for wellness care-associated pneumonia. Arch Intern Med 2008, 168(20):2205210. five. Zilberberg MD, Shorr AF, Micek ST, Mody SH, Kollef MH: Antimicrobial therapy escalation and hospital mortality amongst patients with health-careassociated pneumonia: a single-center expertise. Chest 2008, 134(5):96368. six. Madaras-Kelly KJ, Remington RE, Fan VS, Sloan KL: Predicting antibiotic resistance to community-acquired pneumonia antibiotics in culture-positive sufferers with healthcare-associated pneumonia. J Hosp Med 2012, 7(three):19502. 7. Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJV, Anzueto A, Mortensen EM: Guideline-concordant therapy and outcomes in healthcare-associated pneumonia. Eur Respir J 2011, 38(four):87887. 8. Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR: Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia. Respir Med 2012, 106(11):1606612. 9. Jung JY, Park MS, Kim YS, Park BH, Kim SK, Chang J, Kang YA: Healthcare-associated pneumonia amongst hospitalized individuals in a Korean tertiary hospital. BMC Infect Dis 2011, 11:61. ten. Seki M, Hashiguchi K, Tanaka A, Kosai K, Kakugawa T, Awaya Y, Kurihara S, Izumikawa K, Kakeya H, Yamamoto Y, et al: Qualities and disease severity of healthcare-associated pneumonia amongst sufferers in a hospital in Kitakyushu, Japan. J Infect Chemother 2011, 17(3):36369. 11. Sugisaki M, Enomoto T, Shibuya Y, Matsumoto A, Saitoh H, Shingu A, Narato R, Nomura K: Clinical qualities of healthcare-associated pneumonia within a public hospital within a metropolitan region of Japan. J Infect Chemother: official journal of your Japan Society of Chemotherapy 2012, 18(3):35260. 12. Giannella M, Pinilla B, Capdevila JA, Martinez Alarcon J, Munoz P, Lopez Alvarez J, Bouza E: Pneumonia treated within the internal medicine division: concentrate on healthcare-associated pneumonia. Clin Microbiol Infec: the official publication of your European Society of Clinical Microbiology and Infectious Illnesses 2012, 18(eight):78694. 13. Shindo Y, Ito R, Kobayashi D, Ando M, Ichikawa M, Shiraki A, Goto Y, Fukui Y, Iwaki M, Okumura J, et al: Risk components for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia. Am J Respir Crit Care Med 2013, 188(eight):98595. 14. Ma HM, Ip M, Woo J, Hui DS, Lui GC, Lee NL, Chan PK, Rainer TH: Threat CB1 custom synthesis factors for drug-resistant bacterial pneumonia in older patients hospitalized with pneumonia inside a Chinese population. QJM 2013, 106(9):82329. 15. Falcone M, Corrao S, Licata G, Serra P, Venditti M: Clinical effect of broad-spectrum empirical antibiotic therapy in individuals with healthcare-associated pneumonia: a multicenter interventional study. Intern Emerg Med 2012, 7(6):52331. 16. Carrabba M, Zarantonello M, Bonara P, Hu C, Minonzio F, Cortinovis I, Milani S, Fabio G: Severity assessment of healthcare-associated pneumonia and pneumonia in AT1 Receptor drug immunosuppression. Eur Respir J 2012, 40(5):1201210. 17. Jeong BH, Koh WJ, Yoo H, Um SW, Suh GY, Chung MP, Kim H, Kwon OJ, Jeon K: Performances of prognostic scoring systems in individuals with healthcare-a.